Skip to content
Science

Phage Therapy Researcher

Phage therapy researchers isolate, characterize, and formulate bacteriophages (viruses that specifically infect and kill bacteria) as targeted therapeutic interventions against multidrug-resistant (AMR) bacterial pathogens. In sub-Saharan Africa, where antimicrobial resistance is an escalating public health crisis threatening surgical outcomes and neonatal survival, they build curated phage biobanks, perform genomic sequencing to eliminate lysogenic toxin genes, and design customized phage cocktails to treat intractable clinical and veterinary infections. Emerging technological innovations across Kenyan industrial sectors continue to transform day to day operational workflows, elevating demand for skilled personnel who combine fundamental mastery with modern digital tool proficiencies.

AI exposure
17/100
Low exposure
Monthly pay
KES 100k – 890k
Kenyan market salary band
Hiring outlook
Growing
Annual hiring trajectory
Future proof
90/100
Resilient

The short answer

Will AI take it
17 out of 100, low exposure. About 68% of the tasks still need a person.The detail
Is anyone hiring
Hiring is growing, with net demand +33% over 2024-2030.The detail
What it pays
Starts around KES 100k a month and reaches KES 890k at senior level.The detail
How to get in
KCSE C+ (Bachelor Degree) is the usual minimum, and 8 courses in the catalogue lead to it. About 5 years to a lead role.The detail

The role

What the work is, what it pays, and what it asks of you.

Overview

The field is rapidly developing through high-throughput genomic sequencing, transmission electron microscopy (TEM) virion profiling, and machine learning models predicting phage-receptor binding dynamics. As national medical institutions seek alternative biologics to combat superbugs, researchers must combine sterile laboratory microbiology with compassionate clinical trials and regulatory filings. Career progression advances from molecular microbiologist to lead phage researcher, biotherapeutics director, and clinical translational lead. In the Kenyan context, practitioners must adhere to national statutory frameworks, professional codes of ethics, and industry best practices established by relevant regulatory authorities. Employers increasingly prioritize candidates who demonstrate verified technical qualifications, continuous professional development, and practical problem solving competence.

The double-layer plaque purification protocols, viral genomic characterization procedures, and biosecurity safety standards are internationally harmonized, whether isolating therapeutic phages locally in Kenyan clinical laboratories, publishing infectious disease breakthroughs, or collaborating with global AMR consortia. Career advancement in Kenya typically rewards demonstrated operational reliability, enabling experienced professionals to transition into senior supervisory, quality assurance, or independent technical consulting roles across commercial and public enterprises.

Work environment

Work environment
Biosafety level 2+ microbiology laboratories, biomedical research institutes, university medical centers, and pharmaceutical facilities.
Work style
Experimental, microbiologically meticulous, safety focused, and research driven.
Physical demands
Moderate physical demand during sterile laboratory benchwork, pipetting, and centrifuge operations.
Travel
Minimal to moderate travel for field environmental sample collection across regional water bodies.
Remote working
On-site / field
Freelance potential
Low

A day in the role

Begins the morning screening environmental sewage and water samples using plaque assays to isolate novel lytic phages targeting antibiotic-resistant Klebsiella pneumoniae. Meets with clinical microbiologists at 11 AM to review whole-genome sequencing results confirming the absence of toxin genes. Spends the afternoon in the biosafety laboratory measuring phage burst size and host range kinetics against patient clinical isolates. You coordinate closely with cross functional colleagues to align on immediate deliverables, double checking equipment readiness and standard operating protocols. Throughout the shift, you document system performance metrics, consult with operational supervisors on technical exceptions, and uphold rigorous occupational health and environmental safety protocols.

In the afternoon, you execute core deliverables, consult with cross functional colleagues, document operational outcomes, and ensure that all equipment and handover notes are fully updated before completing the shift. Before completing the shift, you reconcile physical logs, review operational checklists with the oncoming team, archive incident reports, and brief project supervisors on task completion.

What it pays

Kenyan market salary bands, monthly in KES
Entry level
KES 100k – 160k
Mid-level specialist
KES 210k – 410k
Senior / lead
KES 460k – 890k
Salary slope projection (2026 to 2030)
2026entry to senior: 5.2x 4.1x2030

Monthly pay in Kenyan shillings, rounded to the nearest thousand. The shaded band is the distance between entry and senior pay, which is the part that is changing. These are projections, not observations.

The trade-offs

In its favourAgainst it
Direct, life-saving impact providing the ultimate therapeutic cure against incurable antibiotic-resistant superbugs.Host specificity challenge: an isolated phage that cures one patient may completely fail against another patient strain.
High international collaboration with leading phage biobanks and global antimicrobial resistance research consortiums.Strict and slow regulatory approval frameworks for living viral biologicals under the Pharmacy and Poisons Board.
Deeply rewarding intersection of virology, evolutionary biology, clinical infectious disease, and genomic bioinformatics.Endotoxin removal hurdles: purifying Gram-negative phages without residual toxic bacterial cell wall fragments.

In practice

Phage Therapy Researcher in Kenya operates at the strategic intersection of specialized engineering, regional industrial transformation, and sustainable execution. As enterprise organizations, research institutes, and public utilities across East Africa modernize infrastructure, this role provides technical leadership, scalable architecture, and measurable operational resilience.

Core responsibilities encompass system architecture design, rigorous quality and safety assurance, cross-functional stakeholder collaboration, regulatory compliance with Kenyan and regional standards, and continuous performance telemetry monitoring.

Key organizations hiring for this role include Kenya Medical Research Institute (KEMRI), Institute of Primate Research (IPR), International Livestock Research Institute (ILRI), Kenya Science Consortium 4, alongside expanding opportunities in Nairobi, Mombasa, Kisumu, and regional infrastructure projects.

Phage Therapy Researcher Specialist, Senior Phage Therapy Researcher, Phage Therapy Researcher Lead, Phage Therapy Researcher Consultant

Exposure

How much of this a machine can already do, and how that was determined.

Where this rating sits

3,562 rated careers
Mean43
17
020406080100
Rated careers by exposure score
ScoreCareers
0 to 429
5 to 922
10 to 14116
15 to 19290
20 to 24542
25 to 29297
30 to 34305
35 to 39195
40 to 44253
45 to 49279
50 to 54264
55 to 59156
60 to 64101
65 to 69130
70 to 74128
75 to 79151
80 to 84163
85 to 8986
90 to 9454
95 to 991

Rated above 8% of the 3,562 careers in the catalogue, which averages 43. Inside science the mean is 37, across 151 careers.

What the rating is made of

Share of recorded tasks
6%Machine
Machine does it6%
Software can already complete this work end to end.
Machine assists26%
A person still decides, but the drafting is done for them.
Person does it68%
Judgement, relationships and accountability that do not transfer.

Named task by task

Already automated

  • Predict bacteriophage receptor-binding protein structures.
  • Screen phage genomic sequences for antimicrobial resistance and toxin genes.
  • Simulate bacterial mutation escape rates against multi-phage cocktails.
  • Synthesize clinical efficacy trial pharmacokinetic models.

Still human

  • Perform sterile environmental sample isolation and double-layer plaque purification assays.
  • Conduct transmission electron microscopy (TEM) morphological characterization of viral capsids.
  • Design personalized clinical phage cocktail ratios for compassionate-use treatment.
  • Guide national regulatory approvals with the Pharmacy and Poisons Board (PPB).

Your skills, sorted

12 skills recorded

Being absorbed

  • Manual physical counting of clear viral plaque zones on agar petri dishes
  • Routine clerical typing of phage plaque forming unit (PFU) numbers into laboratory logs
  • Standard manual downloading of Sanger sequencing electropherogram trace files
  • Basic manual sorting of cryogenic freezer biobank storage cryovials

Worth more with the tools

  • Machine learning prediction of phage-host interactions and receptor binding affinities from genomic sequences
  • Automated prophage sequence detection ensuring isolated therapeutic phages lack toxin or antibiotic resistance genes
  • Computer vision plaque assay automated counting and viral lysis halo diameter measurement
  • AlphaFold structural prediction modeling phage tail fiber interactions with bacterial lipopolysaccharides

Holding their value

  • Designing compassionate-use emergency clinical protocols for terminal septic patients with no antibiotic options
  • Evaluating phage bioethics and safety clearances under national pharmaceutical clinical trials rules
  • Directing collaborative superbug surveillance partnerships with major Kenyan referral hospital ICUs
  • Navigating international Nagoya Protocol material transfer agreements for sovereign African microbial strains

The six things it was scored on

0 to 100 each
Regulatory stakeslowers exposure
95

Where a named person has to carry the liability.

Digital surfaceraises exposure
90

How much of the work already happens inside software.

People and inventionlowers exposure
84

Work that needs trust, persuasion or an original idea.

Physical presencelowers exposure
48

Work that has to happen in a place, with hands.

Rule bound thinkingraises exposure
25

Decisions that follow a procedure rather than a judgement.

Routine intensityraises exposure
22

How much of it repeats in the same shape each time.

Task counts

Tasks recorded
15
Automatable now
3
Still human
5
Displacing
Manual plaque counting technician,Paper strain catalog filing clerk,Routine phage lysate filtration assistant
Augmenting
Phage-host interaction prediction in silico,Automated viral genomic safety screening,Plaque assay computer vision enumeration
Creating
Phage Genomics Biobank Architect,Synthetic Phage Tail Fiber Engineer,Antimicrobial Resistance Surveillance Lead

Sources

Behind the rating

Getting in

The routes into the role, credentials, and tools required.

What to study

8 courses

How people get in

  • Microbiology Degree Pathway

    4 yearsMedium cost

    Bachelor degree in Microbiology, Molecular Biology, or Biotechnology from premier Kenyan universities.

  • Medical Virology Pathway

    2 yearsMedium cost

    Microbiologists pursuing postgraduate research in therapeutic bacteriophage isolation and clinical translation.

Industry certifications

2 verified credentials
  • Biosafety & Biosecurity Officer Certification

    IFBAKsh 45,0003 months

  • Good Laboratory Practice (GLP) Specialist

    WHOKsh 30,0002 months

Tools of the trade

5 core toolchains

Who hires

4 verified employers

Interview preparation

3 curated questions
  • Why is it strictly mandatory to perform whole-genome sequencing on candidate therapeutic bacteriophages before clinical formulation?

    TechnicalSenior

    Demonstrate understanding of phage genomics, transduction risks, and patient safety criteria.

  • A target bacterial clinical strain evolves resistance against a primary therapeutic phage in vitro. How do you respond?

    SituationalSenior

    Show understanding of bacterial-phage co-evolution and evolutionary trade-off exploitation.

  • Describe handling a regulatory consultation where medical authorities were hesitant to approve a virus-based compassionate therapy.

    BehaviouralMid

    Highlight communication clarity, patience, and authoritative scientific advocacy.

Common misconceptions

  • Bacteriophages are dangerous viruses that infect and sicken human patients.

    Bacteriophages are completely harmless to humans; they exclusively hunt, infect, and kill specific bacterial cells.

  • Phage therapy is an unproven fringe science that has never been tested in medicine.

    Phage therapy has been used safely for over a century in Eastern Europe and is now being adopted in mainstream Western hospitals against superbugs.

  • A single phage cocktail can cure every bacterial infection known to medicine.

    Phages are extraordinarily host-specific, requiring precise isolation and matching against a patient specific bacterial strain.

  • Bacteria can never evolve resistance against predatory bacteriophages.

    Bacteria evolve phage resistance, but unlike chemical antibiotics, phages constantly co-evolve and mutate to overcome bacterial defenses.

  • Extracting phages from hospital sewage makes them dangerously dirty for medical use.

    Phages are purified through cesium chloride gradient ultracentrifugation and endotoxin removal columns, achieving sterile cGMP grade purity.

  • Phage therapy research has zero relevance to East Africa.

    Kenya faces alarming rates of multi-drug-resistant hospital superbugs (ESKAPE pathogens) where phages provide a life-saving alternative to failing antibiotics.

Professional bodies & associations

  • International Society for Viruses of Microorganisms (ISVM)
  • Kenya Society of Microbiologists (KSM)
  • Biochemical Society of Kenya (BSK)
  • Kenya Medical Research Institute Scientific Advisory Council (KEMRI)

What happens next

How the role evolves from here, and where it leads.

How the role changes

2024-2030

Through 2030, phage therapy researchers will advance from academic wastewater sampling to managing accredited national phage biobanks and automated synthetic biology biofoundries that formulate customized personalized phage treatments within 24 hours across East Africa.

  1. 2024already here

    Establishment of Kenya first therapeutic bacteriophage biobank repository at KEMRI.

  2. 2026already here

    Successful compassionate-use clinical trials of lytic phage cocktails treating drug-resistant osteomyelitis.

  3. 2028projected

    Regulatory approval of prophylactic agricultural phage formulations for commercial broiler farms.

  4. 2030projected

    Standardized point-of-care rapid phage susceptibility matching deployed across major Kenyan hospitals.

The near term

2026-2028

Low disruption

Escalating antimicrobial resistance in East African hospitals and livestock herds drives clinical isolation and biobanking of therapeutic bacteriophages targeting multi-drug resistant pathogens.

Tasks automated by 2028
20%
Practitioners augmented
74%
Displacement risk
6%
New roles created
34%
  • Hospitals partner with research biobanks to supply tailored phage cocktails for untreatable diabetic foot ulcers
  • Veterinary poultry farms adopt water-additive phage formulations to eradicate multi-drug resistant Salmonella
  • Whole-genome sequencing of phage isolates ensures absence of lysogenic integration or bacterial toxin genes
What to do
Isolate lytic phages from regional wastewater and agricultural runoffs, screen host ranges, sequence phage genomes using PHASTER to exclude toxin genes, and prepare compassionate-use clinical protocols.

Market outlook

Net demand, 2024-2030
+33%
Demand
87 of 100
Supply pressure
7 of 100
Balance
Acute scarcity
Driving demand
  • Alarming rise in multi-drug-resistant bacterial infections in Kenyan hospitals exhausting reserve antibiotics
  • Establishment of regional phage therapy biobanks and clinical trials at KEMRI and partner universities
  • Surging international donor funding for non-antibiotic alternatives to combat global superbugs
Holding it back
  • Lack of established regulatory pathways for biological phage cocktails under regional drug authorities
  • High costs of cGMP cleanroom facilities required for sterile human clinical injectable production

How to stay ahead

  • Immediate (Months 1-6)

    Isolate lytic bacteriophages from wastewater targeting multidrug-resistant hospital pathogens (Klebsiella, Pseudomonas).

  • Medium Term (Months 7-18)

    Build standardized phage biobanks and characterize phage host ranges and genomic stability for compassionate-use clinical trials.

  • Long Term (Months 19-36)

    Advance to Director of Phage Therapeutics or Principal Antimicrobial Resistance Scientist for national health research bodies.

  • Master emerging AI workflow automation and predictive analytics tools specific to Phage Therapy Researcher operations

What to learn

  • Bacteriophage isolation, plaque purification, and high-titer lysate propagation methodologies
  • Phage genomics, lifestyle determination (lytic vs lysogenic), and prophage identification in PHASTER
  • Endotoxin removal and lipopolysaccharide (LPS) purification using fast protein liquid chromatography (FPLC)
  • Pharmacy and Poisons Board (PPB) compassionate-use experimental therapeutic protocols
  • AI assisted workflow orchestration and computerized data management for Phage Therapy Researcher

AI tools worth knowing

  • PHASTER Prophage Identifier

    Priority: Essential

    Rapid identification and annotation of prophage sequences within bacterial and viral genomes

  • Geneious Phage Genomics Suite

    Priority: Essential

    Assembling phage genomes, identifying open reading frames, and screening against virulence factor databases

  • ÄKTA Pure Chromatography

    Priority: Essential

    Preparative ion-exchange and size-exclusion chromatography for sterile phage endotoxin removal

  • SnapGene Molecular Suite

    Priority: Recommended

    In-silico restriction enzyme digestion mapping and genetic circuit verification for engineered phages

Where people move next

2 recorded moves
  1. 01Synthetic Biology ScientistStep upModerateexposure 186-12 monthspay +22%76%
  2. 02Medicinal Mycology SpecialistSidewaysModerateexposure 206-9 monthspay +10%72%

The bar is the share of skills that carry over from this role, so a longer bar is a shorter move. Step up means the destination is more senior; sideways means it sits at the same level.

Kenyan market notes

Spearheaded by institutions like KEMRI and university research labs addressing AMR pathogens identified as high-priority threats by the World Health Organization (WHO) and Africa CDC. Employment opportunities concentrate across major industrial, commercial, and financial hubs including Nairobi, Mombasa, Kisumu, Nakuru, and Eldoret, alongside specialized regional project sites. Remuneration varies between private contracting firms and institutional employers, with certified practitioners enjoying substantial premiums, overtime allowances, and supervisory advancement opportunities. Continuous industrial modernization across Kenya sustains robust demand for certified practitioners with verifiable technical competence and practical operational excellence. Public and private capital investments continue to expand local career opportunities, incentivizing technical upskilling and long-term professional development across Kenyan economic sectors.

Further reading